Last updated: July 17, 2026

Application No. 18/701,885

2-FLUORODESCHLOROKETAMINE FOR TREATMENT OF DEPRESSION, INCLUDING TREATMENT-RESISTANT DEPRESSION

Non-Final OA

Filed

Apr 16, 2024

Priority

Oct 18, 2021 — provisional 63/256,728 +1 more

Examiner

CLARK, AMY LYNN

Art Unit

1628

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Clearmind Labs Corp.

OA Round

1 (Non-Final)

This examiner grants 39% of cases after interview

— +30.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 920 resolved cases, 2023–2026

Examiner Intelligence

CLARK, AMY LYNN View full profile →

Grants only 39% of cases

Career Allowance Rate

360 granted / 920 resolved

-20.9% vs TC avg

Strong +31% interview lift

Without

With

+30.9%

Interview Lift

resolved cases with interview

Typical timeline

4y 1m

Avg Prosecution

25 currently pending

Career history

940

Total Applications

across all art units

Statute-Specific Performance

§101

3.1%

-36.9% vs TC avg

§103

70.2%

+30.2% vs TC avg

§102

12.2%

-27.8% vs TC avg

§112

5.8%

-34.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 920 resolved cases

Prosecution Timeline

Apr 16, 2024

Application Filed

Jun 02, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/031,805

Patent 12611487

MULTILAYER ENGINEERED HEART MUSCLE

3y 0m to grant Granted Apr 28, 2026

18/091,431

Patent 12509487

NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS

3y 0m to grant Granted Dec 30, 2025

16/641,417

Patent 12478671

STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS

5y 9m to grant Granted Nov 25, 2025

18/616,995

Patent 12410210

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

1y 5m to grant Granted Sep 09, 2025

18/463,293

Patent 12404298

GLUCOCORTICOID RECEPTOR AGONISTS

1y 12m to grant Granted Sep 02, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

39%

Grant Probability

70%

With Interview (+30.9%)

4y 1m (~1y 10m remaining)

Median Time to Grant

Low

PTA Risk

Based on 920 resolved cases by this examiner. Grant probability derived from career allowance rate.